XML 33 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit - USD ($)
$ in Thousands
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Accumulated Other Comprehensive Loss
Total
Ending balance at Dec. 31, 2022 $ 19 $ 446 $ (45,492) $ (24) $ (45,051)
Ending balance (in shares) at Dec. 31, 2022 19,127,914        
Ending balance at Dec. 31, 2022         $ 85,503
Ending balance (in shares) at Dec. 31, 2022         29,555,538
Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit          
Exercise of stock options   2     $ 2
Exercise of stock options (in shares) 6,250        
Stock-based compensation   314     314
Maturities of short-term investments       24 24
Net loss     (17,347)   (17,347)
Ending balance at Dec. 31, 2023 $ 19 762 (62,839)   $ (62,058)
Ending balance (in shares) at Dec. 31, 2023 19,134,164       19,134,164
Ending balance at Dec. 31, 2023         $ 85,503
Ending balance (in shares) at Dec. 31, 2023         29,555,538
Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit          
Exercise of stock options   5     $ 5
Exercise of stock options (in shares) 63,750        
Stock-based compensation   81     81
Net loss     (4,202)   (4,202)
Ending balance at Mar. 31, 2024 $ 19 848 (67,041)   (66,174)
Ending balance (in shares) at Mar. 31, 2024 19,197,914        
Ending balance at Mar. 31, 2024         $ 85,503
Ending balance (in shares) at Mar. 31, 2024         29,555,538
Beginning balance at Dec. 31, 2023 $ 19 762 (62,839)   $ (62,058)
Beginning balance (in shares) at Dec. 31, 2023 19,134,164       19,134,164
Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit          
Exercise of stock options   5     $ 5
Exercise of stock options (in shares) 63,750       63,750
Stock-based compensation   319     $ 319
Net loss     (29,397)   (29,397)
Ending balance at Dec. 31, 2024 $ 19 1,086 (92,236)   $ (91,131)
Ending balance (in shares) at Dec. 31, 2024 19,197,914       19,197,914
Beginning balance at Dec. 31, 2023         $ 85,503
Beginning balance (in shares) at Dec. 31, 2023         29,555,538
Ending balance at Dec. 31, 2024         $ 85,503
Ending balance (in shares) at Dec. 31, 2024         29,555,538
Statements of Redeemable Convertible Preferred Stock and Stockholders' Deficit          
Exercise of stock options   3     $ 3
Exercise of stock options (in shares) 5,416       5,416
Stock-based compensation   80     $ 80
Net loss     (9,579)   (9,579)
Ending balance at Mar. 31, 2025 $ 19 $ 1,169 $ (101,815) $ 2 $ (100,625)
Ending balance (in shares) at Mar. 31, 2025 19,203,330       19,203,330
Ending balance at Mar. 31, 2025         $ 85,503
Ending balance (in shares) at Mar. 31, 2025         29,555,538